Cancer Drug Price Caps: Are They the Best Solution?
Cancer drug price caps are set to reduce costs by up to 70%.
Cancer drug price caps are set to reduce costs by up to 70%.
Cancer drug prices are set to fall significantly, with a reduction of up to 70% starting Nov 9.
Aumolertinib approval revoked due to data protection breach. Discover the implications for patients and the pharmaceutical industry.
China approval antipsychotic drug offers new hope for patients seeking effective mental health treatments. Discover the implications of this breakthrough.